---
document_datetime: 2025-03-31 10:11:57
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/efmody-epar-all-authorised-presentations_en.pdf
document_name: efmody-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.9776195
conversion_datetime: 2025-12-20 11:45:17.338754
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form            | Route of Administration   | Immediate Packaging   | Pack size             |
|------------------|-------------------|------------|--------------------------------|---------------------------|-----------------------|-----------------------|
| EU/1/21/1549/001 | Efmody            | 5 mg       | Modified-release capsule, hard | Oral use                  | bottle (HDPE)         | 50 capsules           |
| EU/1/21/1549/002 | Efmody            | 10 mg      | Modified-release capsule, hard | Oral use                  | bottle (HDPE)         | 50 capsules           |
| EU/1/21/1549/004 | Efmody            | 5 mg       | Modified-release capsule, hard | Oral use                  | bottle (HDPE)         | 100 (2 x 50) capsules |
| EU/1/21/1549/005 | Efmody            | 10 mg      | Modified-release capsule, hard | Oral use                  | bottle (HDPE)         | 100 (2 x 50) capsules |